|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-12-11
|
|
pubmed:abstractText |
Stage IIIb (T4/N3) non-small-cell lung cancer (NSCLC) is considered an inoperable disease and treatment is an enduring challenge. Surgery after induction therapy seems to improve locoregional control. We report the results of a phase II prospective trimodality trial (chemotherapy and concomitant radiotherapy plus surgery) in patients with stage IIIb NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1802-8; discussion 1808-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14667587-Adult,
pubmed-meshheading:14667587-Aged,
pubmed-meshheading:14667587-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14667587-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:14667587-Cisplatin,
pubmed-meshheading:14667587-Combined Modality Therapy,
pubmed-meshheading:14667587-Disease-Free Survival,
pubmed-meshheading:14667587-Female,
pubmed-meshheading:14667587-Fluorouracil,
pubmed-meshheading:14667587-Humans,
pubmed-meshheading:14667587-Lung Neoplasms,
pubmed-meshheading:14667587-Male,
pubmed-meshheading:14667587-Middle Aged,
pubmed-meshheading:14667587-Pneumonectomy,
pubmed-meshheading:14667587-Postoperative Complications,
pubmed-meshheading:14667587-Prospective Studies,
pubmed-meshheading:14667587-Radiotherapy Dosage,
pubmed-meshheading:14667587-Survival Analysis,
pubmed-meshheading:14667587-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.
|
|
pubmed:affiliation |
Department of Surgical Sciences, Catholic University, Rome, Italy. mimgaleta@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
